Our Blog | Biosimilars & Generics | AAM

AAM All Access Podcast - Dan Leonard interviews pharmaceutical industry veteran Bob Billings

AAM All Access Podcast

Jan 4, 2022 | Dan Leonard

AAM All Access Podcast: Bob Billings

Professional nurse does checkup of patient's intravenous and IV fluid bag

Dec 20, 2021 | Craig Burton

Proposed BBB Negotiation Framework Discourages Biosimilar Competition, Imposes Higher Costs on Commercially Insured Patients and Their Employers

Ramprasad Reddy

Dec 14, 2021 | Bob Billings

Thank you, Ramprasad Reddy

Vial and syringe injection

Dec 3, 2021 | Craig Burton

The Evidence Is Clear: Biosimilar Competition Will Achieve More Savings for Patients Than Build Back Better’s Negotiations

Dec 2, 2021 | Monét Stanford

How Inflation Penalties for Generic Medicines Could Worsen Drug Shortages

2021 U.S. Generic and Biosimilar Medicines Savings Report

Nov 30, 2021 | Erica Klinger

GRx+Biosims 2021 | Generics + Biosimilars Conference

Nov 29, 2021 | Erica Klinger

Process & Progress: A Recap of GRx+Biosims 2021

AAM All Access Podcast

Nov 20, 2021 | Dan Leonard

AAM All Access Podcast: Lachman Consultants’ Robert Pollock

Female pharmacist services senior female customer buying prescription medicine package and paying using contactless method

Nov 15, 2021 | Craig Burton

Inflation Rebate Proposal Builds on Bad Policy for Generics

HHS Proposal Will Help America’s Patients Realize the Full Value of Their Generics and Biosimilars

Nov 12, 2021 | Monét Stanford

Medicare Negotiations Serve as a Catalyst to a Perpetual Monopoly

Cover of A Blueprint for Enhancing the Security of the U.S. Pharmaceutical Supply Chain

Nov 2, 2021 | Jonathan Kimball

Second Edition of AAM’s Blueprint to Enhance the Security of the U.S. Pharmaceutical Supply Chain

AAM All Access Podcast

Oct 27, 2021 | Dan Leonard

AAM All Access Podcast: Celebrating Pharmacists